Ipierian's patent application for iPS cells in Canada raises concerns

11/2/2010 | Ottawa Citizen (Ontario)

Ipierian has filed an application with the Canadian government seeking patent rights for induced pluripotent stem cells and a human stem cell that is pluripotent and can self-regenerate in the long term, among other characteristics. However, some experts say researchers could face restrictions in gaining access to stem cells if such a comprehensive claim gets patent approval.

View Full Article in:

Ottawa Citizen (Ontario)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC